Clinical Trials Browser

Terminated × NIH × Head & Neck × Clear all

NCT04458909 2025-10-03

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Phase 3 Terminated

15 enrolled 17 charts

Nasopharyngeal Carcinoma

NCT02917629 2023-03-08

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Phase 2 Terminated

6 enrolled 22 charts

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00393224 2020-06-04

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Neoplasms, Virus Diseases

NCT01257100 2020-06-04

Environmental and Genetic Determinants of NPC

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT01479348 2020-06-02

Imaging Study for FdCyd and THU Cancer Treatment

Phase EARLY_PHASE1 Terminated

5 enrolled 12 charts

BreastGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms

NCT01265381 2020-03-03

Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study

Thyroid Neoplasms

NCT03002623 2018-12-21

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Phase 2 Terminated

7 enrolled 13 charts

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT00923247 2018-11-29

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Phase 1/2 Terminated

22 enrolled 21 charts

Neoplasms, Thyroid Neoplasms, Carcinoma, Medullary

NCT00342693 2018-04-05

Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine

Neoplasms, Thyroid Diseases

NCT00126568 2018-01-19

Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer

Phase 2 Terminated

20 enrolled 10 charts

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT01267240 2017-04-14

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase 2 Terminated

25 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck

NCT01838642 2017-02-15

Ponatinib for Advanced Medullary Thyroid Cancer

Phase 2 Terminated

3 enrolled 13 charts

Thyroid Neoplasms

NCT00951379 2016-04-06

Pioglitazone for Oral Premalignant Lesions

Phase 2 Terminated

52 enrolled 23 charts

Leukoplakia, Oral

NCT00088907 2015-05-06

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

Phase 3 Terminated

270 enrolled 8 charts

Head and Neck Neoplasms

NCT00571558 2014-10-09

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia

Phase 1 Terminated

Leukoplakia, Oral

NCT00095693 2014-01-16

Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer

Phase 2 Terminated

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Thyroid Carcinoma, Anaplastic

NCT00906360 2013-07-02

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00062387 2013-06-03

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00126607 2013-02-28

Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Phase 2 Terminated

Salivary Gland Neoplasms

NCT00033449 2013-01-25

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck